Equity Analysis /
United States of America

US : Mirum Pharmaceuticals, Inc. - MIRM | Liv'in it up: Livmarli Approved in Alagille Syndrome

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    29 September 2021
    Published by